Gilead Sciences Announces Steps to Expand Availability of Remdesivir in IndiaBusiness Wire • 04/26/21
Will Strong Veklury and HIV Sales Aid Gilead's (GILD) Q1 Earnings?Zacks Investment Research • 04/23/21
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapiesGlobeNewsWire • 04/23/21
Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021Business Wire • 04/15/21
Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial CancerPRNewsWire • 04/14/21
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial CancerBusiness Wire • 04/13/21
Everest Medicines Announces that Licensing Partner Gilead Sciences, Inc. has Received Full US FDA Approval of Trodelvy® for the Treatment of Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast CancerPRNewsWire • 04/09/21
Biotech Stocks Could Use A Win — Will The First Quarter Offer That?Investors Business Daily • 04/08/21